All In Biotech

Free tool

FAERS Monitor: Emsam

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021708 or its brand name (Emsam, Selegiline). Reports on generic versions are filed under their own applications.

Reports

2,999

Serious

1,411

47% of reports

Hospitalization

598

Death reported

174

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective329
  • insomnia189
  • application site erythema183
  • hallucination171
  • dizziness170
  • fall147
  • dyskinesia140
  • drug interaction135
  • anxiety128
  • depression128
  • application site rash127
  • tremor121
  • application site pruritus120
  • confusional state118
  • fatigue115

Reports by year received

View as table
YearReports
20041
20052
200635
2007311
200827
200943
201034
2011203
2012182
2013145
201451
2015199
2016194
2017224
2018174
2019195
2020193
2021165
2022129
2023147
2024112
2025132
2026100

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,160 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
application site rashSignal12765.455.17,917
application site erythemaSignal18349.342.88,563
application site pruritusSignal12037.331.34,184
dyskinesiaSignal14024.220.63,091
hallucinationSignal17115.913.82,384
drug interactionSignal1356.05.1558
confusional stateSignal1185.14.3390
tremorSignal1215.14.3399
insomniaSignal1895.04.3604
depressionSignal1283.93.3282
anxietySignal1283.22.7189
fallSignal1473.12.6210
dizzinessSignal1702.42.1139
drug ineffective3291.81.6112
fatigue1151.00.90

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.